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Small stent lumen area (LA) and residual inflow/outflow disease have been reported as the strongest IVUS predictors of stent thrombosis (ST) in pts 
with stable angina. Predictors of ST in pts with STEMI have not been studied. 
Methods: In HORIZONS-AMI, STEMI pts <12h after symptom onset were randomized 1:1 to bivalirudin alone vs. heparin + GPIIb/IIIa inhibitor and 
3:1 to paclitaxel-eluting (PES) vs. bare metal stents. A formal IVUS substudy included post-stent and 13-month follow-up imaging at 36 centers. 
Twelve pts with baseline IVUS who had ST within 30d after enrollment were compared to 388 pts without early ST. Significant residual stenosis was 
defined as LA <4.0mm2 with ≥70% plaque burden <10mm from a stent edge. Significant edge dissection was ≥medial dissection with LA <4mm2. 
Significant plaque/thrombus protrusion was defined as ≥1.0mm2 intrastent plaque/thrombus area. Significant acute malapposition was defined as 
≥1.5mm2 malapposed area. 
Results: Randomization to bivalirudin (p=0.4) or PES (p=0.7) was not related to early ST. Minimum LA (but not minimum stent area) was smaller 
in pts with vs. without early ST (Table). Significant stent edge dissection and residual stenosis were also more prevalent in pts with ST; acute 
malapposition or plaque/tissue protrusion was not (Table). 
Conclusions: Smaller final minimum LA and inflow/outflow disease (from residual stenosis or dissection), but not acute malapposition or stent 
type, are important predictors of early (<30d) ST after STEMI intervention.
Table. Comparison of IVUS Findings between ST vs no ST
Stent Thrombosis n=12 No Stent Thrombosis n=391 p value
Minimum LA, mm2
Minimum LA <5.0 mm2, n (%)
5.7±3.5
5 (41.7)
6.7±2.0
67 (17.1)
0.01
0.047
Minimum stent area, mm2 6.3 ± 3.2 6.9 ± 2.1 0.68
Stent expansion 0.73 ± 0.20 0.75 ± 0.16 0.63
Stent length, mm 41.5 ± 25.7 27.6 ± 12.5 0.11
Acute stent malapposition, n (%) 0 (0) 79 (20.2) 0.13
Plaque/thrombus protrusion, n (%) 8 (66.7) 163 (41.7) 0.14
Stent edge dissection, n (%) 5 (41.7) 7 (1.8) <0.001
Residual stenosis, n (%) 6 (50.0) 15 (3.8) <0.001
At least 1 abnormal finding*, n (%)
*Abnormal finding includes residual disease, significant dissection, and 
minimum LA <5mm2.
12 (100.0) 86 (22.0) <0.001
